ARCA BIOPHARMA ANNOUNCES COMPLETION OF FDA PRE-IND CONSULTATION UNDER CORONAVIRUS TREATMENT ACCELERATION PROGRAM FOR AB201 AS A POTENTIAL TREATMENT FOR SEVERE COVID-19 Posted on August 12, 2020 by ARCA IT - Press Release, Uncategorized AB201-COVID-Pre-IND-Completed
ARCA BIOPHARMA ANNOUNCES SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Posted on August 5, 2020 by ARCA IT - Press Release, Uncategorized ARCA-2Q20-Financial-Results-and-Business-Update